Disclosure Of Cash Flow Statement [Text Block]

ERYTECH Pharma S.A. - Filing #2810992

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Disclosure of cash flow statement [text block]
Cash and cash equivalents in subsidiary or businesses acquired or disposed
10,000 EUR
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
10 474 EUR
38 789 EUR
33 699 EUR
44 446 EUR
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
294,000 EUR
3,000 EUR
2,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.